SIM
PCRX icon

Strategic Investment Management’s Pacira BioSciences PCRX Stock Holding History

Strategic Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,436
Closed -$236K – 124
2014
Q3 		$236K Buy
+2,436
New +$237K 0.07% 57

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Strategic Investment Management's PCRX Position: Q4 2014 in Review

Strategic Investment Management sold out of Pacira BioSciences (PCRX) in Q4 2014, closing a stake of 2,436 shares — an estimated $236K sold.

Strategic Investment Management first reported a position in PCRX in Q3 2014 and held it in 1 quarter. The position peaked at $236K in Q3 2014. 200 funds tracked by Wall St. Rank hold PCRX as of Q4 2014.

  • Strategic Investment Management reported no remaining Pacira BioSciences position as of Q4 2014 after selling out during the quarter.
  • Strategic Investment Management sold 2,436 Pacira BioSciences shares in Q4 2014, an estimated $236K.
  • Strategic Investment Management first reported a position in Pacira BioSciences in Q3 2014 and held it in 1 quarter.
  • Strategic Investment Management's Pacira BioSciences position peaked at $236K in Q3 2014.
  • 200 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2014.

Based on Strategic Investment Management's 13F filing for Q4 2014, filed 13 Feb 2015.